Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates

Methods in Molecular Biology

Volumn 1066, Issue , 2013, Pages 185-199

  Yabluchanskiy, Andriy ^a   Li, Yaojun ^a   De Castro Brás, Lisandra E ^a   Hakala, Kevin ^a   Weintraub, Susan T ^a   Lindsey, Merry L ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac remodeling; Extracellular matrix; Matrix metalloproteinase; Mice; Myocardial infarction; Proteomics; Substrates

Indexed keywords

FIBRONECTIN; MATRILYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; EX VIVO STUDY; EXPERIMENTAL MODEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

MUS;

ANIMALS; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HEART VENTRICLES; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; PROTEOME; VENTRICULAR REMODELING;

EID: 84934437768     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-604-7_16     Document Type: Article

References (25)

1. Dixon JA, Spinale FG (2011) Myocardial remodeling: Cellular and extracellular events and targets. Annu Rev Physiol 73:47-68
2. Lindsey ML, Weintraub ST, Lange RA (2012) Using extracellular matrix proteomics to understand left ventricular remodeling. Circ Cardiovasc Genet 5:o1-7
3. Gajarsa JJ, Kloner RA (2011) Left ventricular remodeling in the post-infarction heart: A review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 16:13-21
4. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233
5. Kandalam V, Basu R, Abraham T et al (2010) Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. Am J Physiol Heart Circ Physiol 299:H1012-1023
6. Lindsey ML, Zamilpa R (2012) Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther 30:31-41
7. Lindsey ML, Escobar GP, Dobrucki LW et al (2006) Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 290:H232-239
8. Lindsey ML, Escobar GP, Mukherjee R et al (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113:2919-2928
9. Agnihotri R, Crawford HC, Haro H et al (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276:28261-28267
10. Siri A, Knauper V, Veirana N et al (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270:8650-8654
11. von Bredow DC, Nagle RB, Bowden GT et al (1995) Degradation of fi bronectin fi brils by matrilysin and characterization of the degradation products. Exp Cell Res 221:83-91
12. Imai K, Yokohama Y, Nakanishi I et al (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 270:6691-6697
13. Lee KH, Choi EY, Hyun MS et al (2007) Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF- induced in vitro invasion in human stomach cancer cells. Eur Surg Res 39:208-215
14. Belaaouaj AA, Li A, Wun TC et al (2000) Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem 275:27123-27128
15. Crabbe T, Smith B, O'Connell J et al (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett 345:14-16
16. Trocme C, Gaudin P, Berthier S et al (1998) Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem 273:20677-20684
17. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
18. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92:827-839
19. Tan RJ, Liu Y (2012) Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Ren Physiol 302:F1351-1361
20. Yu Q, Stamenkovic I (2000) Cell surfacelocalized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176
21. McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 13:534-540
22. Zamilpa R, Lopez EF, Chiao YA et al (2010) Proteomic analysis identifi es in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics 10:2214-2223
23. Chiao YA, Zamilpa R, Lopez EF et al (2010) In vivo matrix metalloproteinase-7 substrates identifi ed in the left ventricle post-myocardial infarction using proteomics. J Proteome Res 9:2649-2657
24. Haro H, Crawford HC, Fingleton B et al (2000) Matrix metalloproteinase-7- dependent release of tumor necrosis factor-Alpha in a model of herniated disc resorption. J Clin Invest 105:143-150
25. Acuff HB, Carter KJ, Fingleton B et al (2006) Matrix metalloproteinase-9 from bone marrow- derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 66:259-266